Nikko Asset Management Americas’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2M | Sell |
|
|||||
|
2025
Q1 | $44.4M | Sell |
|
|||||
|
2024
Q4 | $60.1M | Sell |
|
|||||
|
2024
Q3 | $63.9M | Sell |
|
|||||
|
2024
Q2 | $74.3M | Sell |
|
|||||
|
2024
Q1 | $103M | Buy |
|
|||||
|
2023
Q4 | $90.6M | Buy |
|
|||||
|
2023
Q3 | $27M | Buy |
|
|||||
|
2023
Q2 | $6.25M | Buy |
|
|||||
|
2023
Q1 | $3.3M | Buy |
|
|||||
|
2022
Q4 | $3.5M | Sell |
|
|||||
|
2022
Q3 | $5.16M | Buy |
|
|||||
|
2022
Q2 | $3.24M | Sell |
|
|||||
|
2022
Q1 | $2.82M | Buy |
|
|||||
|
2021
Q4 | $6.32M | Sell |
|
|||||
|
2021
Q3 | $8.59M | Buy |
|
|||||
|
2021
Q2 | $8.61M | Buy |
|